Vyvanse, Trintellix, Rexulti, Auvelity, Spravato and other ADHD, depression, and anxiety medications. Find manufacturer savings programs and patient assistance.
We'll email you when new manufacturer programs, coupons, or savings cards become available for your medications.
No spam. Unsubscribe anytime.
Manufacturer programs and patient assistance can make branded mental health medications accessible. Many programs offer $0 copay for commercially insured or free medication for uninsured patients.
Mental health medications cover a wide spectrum — from ADHD treatments like Vyvanse to novel antidepressants like Auvelity and the in-office treatment Spravato. Coverage varies widely by insurance plan, and many patients pay full price unnecessarily.
ADHD medications: Vyvanse now has a generic (lisdexamfetamine), which dramatically reduces costs. Azstarys is a newer ADHD medication with a manufacturer savings program. If your ADHD medication is too expensive, ask your prescriber about generic alternatives.
Antidepressants and antipsychotics: Trintellix, Viibryd, Rexulti, Auvelity, and Lybalvi all have manufacturer copay cards for commercially insured patients. Some programs can bring monthly costs to $0. Patient assistance programs are available for uninsured patients whose income qualifies.
Vyvanse (lisdexamfetamine) is now available in generic form, which is significantly cheaper. For branded Vyvanse, Takeda offers a savings card for eligible commercially insured patients. Generic lisdexamfetamine is available at most pharmacies and may be covered by insurance with lower copays.
Yes. Takeda offers a Trintellix savings card for eligible commercially insured patients, which may reduce monthly costs significantly. The Takeda patient assistance program may also offer free Trintellix to qualifying uninsured patients who meet income requirements.
Spravato (esketamine nasal spray) is an in-office treatment, priced at approximately $800–$900 per treatment session. Janssen's support program provides financial assistance for eligible commercially insured patients and may help qualifying uninsured patients access the medication.
Yes. Otsuka and Lundbeck offer a Rexulti Savings Card for eligible commercially insured patients, potentially capping costs at $0–$10/month. The Otsuka Patient Assistance Program may provide free Rexulti to qualifying uninsured patients.